Introduction
human immunodeficiency virus
HUMAN IMMUNODEFICIENCY VIRUS
The use of antiretroviral therapy (ART) in people living with human immunodeficiency virus (PLHIV) has evidently reduced opportunistic infection-related morbidity and mortality [Protease inhibitors are currently recommended as alternative agents for first-, second-, and third-line antiretroviral regimens [Statins possess pleiotropic anti-inflammatory activities in addition to lipid-lowering effects [